4
Changes in Ownership
CLOROX CO /DE/ Filed Acc 0001225208-20-008821
SVP - Chief Innovation Officer sold 25,832 shares at an average $197.62 ($5,104,881)
- SVP - Chief Innovation Officer acquired 26,955 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GARNER DENISE · SVP - Chief Innovation Officer
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-08 | Exercise or conversion : show line 1 in the form | +11,602 | $123.09 | $1,428,090 | 17,468 | D |
| 2020-06-08 | Exercise or conversion : show line 2 in the form | +8,190 | $135.57 | $1,110,318 | 25,658 | D |
| 2020-06-08 | Exercise or conversion : show line 3 in the form | +3,803 | $111.60 | $424,415 | 29,461 | D |
| 2020-06-08 | Exercise or conversion : show line 4 in the form | +3,360 | $151.85 | $510,216 | 32,821 | D |
| 2020-06-08 | Sale : show line 5 in the form | −233 | $194.13 | $45,233 | 32,588 | D |
| 2020-06-08 | Sale : show line 6 in the form | −2,379 | $195.77 | $465,738 | 30,209 | D |
| 2020-06-08 | Sale : show line 7 in the form | −6,569 | $196.74 | $1,292,401 | 23,640 | D |
| 2020-06-08 | Sale : show line 8 in the form | −6,671 | $198.59 | $1,324,823 | 16,969 | D |
| 2020-06-08 | Sale : show line 9 in the form | −9,980 | $198.06 | $1,976,686 | 6,989 | D |
| Open-market sales · 25,832 sh · avg $197.62 · $5,104,881 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-08 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −8,190 | 8,190 | D |
| 2020-06-08 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −11,602 | 3,868 | D |
| 2020-06-08 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −3,803 | 0 | D |
| 2020-06-08 | Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) | −3,360 | 10,080 | D |
Loading xslF345X03/doc4.xml…